IRIS
RICCARDI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.016
EU - Europa 3.274
AS - Asia 2.148
OC - Oceania 22
AF - Africa 8
SA - Sud America 6
Totale 9.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.981
CN - Cina 1.912
UA - Ucraina 802
IE - Irlanda 744
FI - Finlandia 468
DE - Germania 381
SE - Svezia 348
IT - Italia 206
SG - Singapore 180
GB - Regno Unito 175
FR - Francia 77
CA - Canada 34
AU - Australia 20
BE - Belgio 19
CZ - Repubblica Ceca 12
IN - India 11
HK - Hong Kong 9
NL - Olanda 8
RU - Federazione Russa 7
IR - Iran 6
JP - Giappone 6
TR - Turchia 6
EG - Egitto 5
DK - Danimarca 4
GR - Grecia 4
KR - Corea 4
PL - Polonia 4
VN - Vietnam 4
RS - Serbia 3
BR - Brasile 2
CH - Svizzera 2
CL - Cile 2
LT - Lituania 2
MU - Mauritius 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AL - Albania 1
AR - Argentina 1
AT - Austria 1
BD - Bangladesh 1
ID - Indonesia 1
IM - Isola di Man 1
JO - Giordania 1
LK - Sri Lanka 1
LV - Lettonia 1
MX - Messico 1
PE - Perù 1
RO - Romania 1
SI - Slovenia 1
TH - Thailandia 1
YE - Yemen 1
ZA - Sudafrica 1
Totale 9.474
Salva come PNG Salva come JPEG
Città #
Chandler 889
Jacksonville 861
Dublin 743
Nanjing 610
Boardman 284
Nanchang 243
Ashburn 216
Princeton 197
Lawrence 174
Shenyang 168
Changsha 163
Hebei 158
Wilmington 135
Helsinki 133
Singapore 128
Medford 127
Jiaxing 111
Tianjin 107
Hangzhou 93
Beijing 89
Ann Arbor 74
Milan 73
Verona 44
Woodbridge 37
Houston 36
Shanghai 33
Norwalk 30
Kunming 27
Toronto 25
Brussels 19
Seattle 17
Jinan 16
Los Angeles 15
New York 14
San Francisco 14
Pavia 13
Auburn Hills 11
Des Moines 11
Fairfield 11
San Genesio Ed Uniti 11
Melbourne 10
Brno 8
Falls Church 8
Ningbo 8
Zhengzhou 8
Haikou 7
Chicago 6
Lanzhou 6
Guangzhou 5
Taizhou 5
Tappahannock 5
Al Fayyum 4
Canberra 4
Changchun 4
Prague 4
Redwood City 4
Sydney 4
Washington 4
Andover 3
Athens 3
Bački Petrovac 3
Dallas 3
Hanoi 3
Lodi 3
Tokyo 3
Tuglie 3
Warsaw 3
Amsterdam 2
Auckland 2
Bari 2
Barnet 2
Bellshill 2
Borås 2
Buffalo 2
Coimbatore 2
Forest City 2
Frankfurt am Main 2
Ibaraki 2
Incheon 2
Kazan 2
London 2
Naples 2
Nitra 2
Nocera Inferiore 2
Orange 2
Ottawa 2
Paris 2
Riyadh 2
Rockville 2
San Mateo 2
Sha Tin Wai 2
Taichung 2
Amman 1
Andria 1
Ardabil 1
Baranzate 1
Benevento 1
Bloomfield 1
Bridgeport 1
Brookline 1
Totale 6.349
Salva come PNG Salva come JPEG
Nome #
Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6,633 patients from 27 randomized trials. 116
Flow cytometric analysis of circulating dendritic cell subsets and intracellular cytokine production in advanced breast cancer patients 92
A phase II study of sequential 5-fluorouracil, epirubicin and cyclophosphamide (FEC) and paclitaxel in advanced breast cancer (Protocol PV BC 97/01). 85
Long-term effects of parenteral dichloromethylene bisphosphonate (CL2MBP) on bone disease of myeloma patients treated with chemotherapy. 81
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study 78
Response to first-line chemotherapy and long-term survival in patients with multiple myeloma: results of the MM87 prospective randomised protocol 77
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 76
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. VI. Effect of arabinosylcytosine. 75
A study of biological behaviour of human brain tumors. Part I. Arachidonic acid metabolism and DNA content. 74
AIDS-associated non-Hodgkin's lymphomas in Italy: intravenous drug abusers versus homosexual men 74
A prospective comparison of a-IFN and conventional chemotherapy in Ph+ chronic myeloid leukemia. Clinical and cytogenetic results at 2 years in 322 patients 74
- GM-CSF increases dose intensity of chemotherapy in small cell lung cancer. Relationship between clinical results, peripheral blood cell modifications and bone marrow kinetics. 71
Anemie in oncologia. 71
G2 synchronization in human acute leukemia after VP 16 213 therapy. 71
Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register 71
- Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: results from a multinational controlled trial. 70
Cell kinetic characterization of human brain tumors 70
Complications of image-guided transcatheter hepatic chemoembolization of primary and secondary tumours of the liver. 70
Use of bisphosphonates in oncology: physiopathologic bases and clinical activity. 69
OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma. 69
Linee guida per la diagnosi, il trattamento e la riabilitazione del carcinoma polmonare 68
Presentation features of monoclonal gammopathies: analysis of 684 newly diagnosed cases. 68
- Hematological values from quantitative buffy coat analysis (QBC II) system: evaluation in an hematological/oncological outpatient section 68
Sequential administration of interleukin-3 and granulocyte-macrophage colony-stimulating factor following intensified, accelerated CEE (cyclophosphamide, epirubicin, etoposide) chemotherapy: cytokinetic effects on bone marrow hematopoietic progenitors. 67
Advanced breast cancer: a randomized study of different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil. 67
Effect of recombinant gamma interferon on the proliferative activity of cultured leukemic cells. 66
Anemie megaloblastiche. 66
A prospective comparison between treatment with phlebotomy alone and with interferon-alpha in patients with polycythemia vera. 66
Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. 66
Ploidy and proliferative activity in uterine tumors: an in vivo study using bromodeoxyuridine and flow cytometry. 65
I linfomi non Hodgkin (linfosarcomi, reticolosarcomi). 65
The PAS reactivity of lymph-node blast cells in non-Hodgkin's malignant lymphomas. 64
Strategies of medical treatment for metastatic breast cancer 64
Sequential docetaxel and vinorelbine for patients with advanced breast cancer previously treated with anthracyclines: a phase II study. 64
A plea to overcome th concept of "staging" and related inadequacy in multiple myeloma. 64
Effects of desferrrioxamine on normal and leukemic human hematopoietic cell growth: in vitro and in vivo studies 64
Biological effects of pegfilgrastim on circulating neutrophils in breast cancer patients undergoing dose-dense chemotherapy. 64
Anemie megaloblastiche. 64
Angiogenesi: esperienze cliniche 63
Cytokinetic changes in the peripheral blood of leukemic patients during cytostatic therapy. V. Effect of VP 16 213 studied with flow cytofluorometry and cytoautoradiography. 63
Expression of p53 protein during the cell cycle mesaured by flow cytometry in human leukemia. 63
Cell kinetics of CD34-positive hematopoietic cells following chemotherapy plus colony-stimulating factors in advanced breast cancer. 63
Biologia e clinica del mieloma multiplo. 63
Changing clinical presentation of multiple myeloma. 63
Cytokinetic studies in two cases of plasma cell leukemia. 63
Microwave ablation of hepatocellular carcinoma using a new percutaneous device: preliminary results. 63
DNA content analysis of peripheral blood B-lymphocytes in plasma cell malignancies 62
Recombinant human interleukin-11 (Neumega, rhIL-11) reduces thrombocytopenia in breast cancer patients receiving tandem autologous circulating progenitor cell transportation. 61
Studio morfologico e citochimico dei megacariociti in 25 casi di displasie emopoietiche. 60
Effect of Vincristine on the bone marrow cells of patients with multiple myeloma: a cytomorphologic study. 60
Left ventricular function in colon cancer patients receiving adjuvant fluoro-folate chemotherapy. An echocardiographic study. 60
Double heterozygosity for haemoglobin Malmø [ß97 (FG4) His-Glu] and ß-thalassemia traits, with unusually high haematocrit values, in a Sicilian man. 60
Unusual manifestations of disseminated neoplasia at presentation: right-sided heart failure due to a massive cardiac metastasis and autoimmune thrombocytopenia in pleomorphic rhabdomyosarcoma of the adult. 60
High-dose chemotherapy (HDT) with tandem autologous peripheral blood cells (PBPC) transplantation for patients with metastatic breast cancer (MBC) 60
Cell kinetics with in vivo bromodeoxyuridine and flow cytometry: clinical significance in acute non lymphoblastic leukemia. 60
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 60
A rapid cytofluorometric method for quantitative DNA determination on fixed smears. 59
Doubling the epirubicin dosage in the 5-fluorouracil, epirubicin and cyclophosphamide (FEC) regimen for advanced breast cancer: a prospective, randomized, multicentric study on antitumor effect and life quality 59
Paclitaxel in anthracycline-treated breast cancer patients. 59
Interferon alpha-2b in the long-term treatment of essential thrombocythemia. 59
Pro-neoangiogenic cytokines (VEGF and bFGF) and anemia in solid tumor patients 59
Cell kinetic studies of human intracranial tumors. 59
Cancer chemotherapy-related thrombotic thrombocytopeic purpura: biological evidence of increased nitric oxide production. 59
Sequential vincristine, arabinosylcytosine and daunomycin in acute leukemia: a preliminary report. 59
Transhepatic arterial chemoembolization with oxaliplatin-eluting microspheres (OEM-TACE) for Unresectable Hepatic Tumors. 59
Nuove strategie di impiego dei fattori di crescita mielopoietici. 58
Epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer: results and open issues. 58
Sustained complete hematological remission in essential thrombocythemia after discontinuation of long-term a-IFN treatment. 58
Interim analysis of the Grocta 8 adjuvant trial in breast cancer patients with ten or more involved nodes 57
New agents in medical oncology and the risk of venous thromboembolism. 57
Il carcinoma mammario operabile. Linee guida per la diagnosi, il trattamento e la riabilitazione. 57
Weekly taxanes in metastatic breast cancer. 56
Flow cytometric DNA index in the prognosis of colorectal cancer. 56
HER-2 / neu oncogene expression and DNA ploidy in normal human kidney and renal cell carcinoma. 56
Expression of p170 multidrug resistance protein in multiple myeloma: a clinical study. 56
Myelodysplastic syndromes: biologic and clinical aspects. 56
Applicazioni cliniche dei fattori di crescita emopoietici. 56
Gemcitabine and oxaliplatin to treat immunotherapy-resistant advanced renal cell carcinoma patients: final results of a single institution phase II study 56
VEGF-induced intracellular Ca2+oscillations are down-regulated and do not stimulate angiogenesis in breast cancer-derived endothelial colony forming cells 56
Cell cycle status and apoptosis of hematopoietic progenitor cells released into the peripheral blood after taxanes anf granulocyte colony-stimulating factor in breast cancer patients 55
Prerequisites for in vivo cell kinetic studies in patients. 55
Sequential intrahepatic and systemic fluoropyrimidines-based chemotherapy for metastatic colorectal cancer confined to the liver. A phase II study. 55
Intrathecal methotrexate neurotoxicity. 55
P-glycoprotein expression in multiple myeloma. 55
Intravenous carboplatin and etoposide for recurrent malignant glioma: a phase II study. 55
Applicazioni cliniche della citometria. 55
Intravenous or oral vinorelbine plus capecitabine as first - line treatment in HER2- metastatic breast cancer: Joint Analysis of 2 Consecutive Prospective Phase II Trials. 55
Bone marrow myeloid cell kinetics during treatment of small cell carcinoma of the lung with chemotherapy not associated and associated with granulocyte-macrophage colony stimulating factor. 54
The use of peripheral blood haemopoietic progenitors mobilized with standard dose chemotherapy plus G-CSF to support multicyclic dose-intensive chemotherapy for advanced breast cancer. 54
Circulating progenitor cell release and funtional characterization after topotecan plus G-CSF and erythropoietin in small cell lung cancer patients. 54
Fisiopatologia dell'eritrocito. 54
Flow cytometric determination of ploidy and proliferative activity on isolated bone marrow particles and on total bone marrow aspirate. 53
Flow cytometric analysis of multidrug resistance antigen (p glicoprotein) and DNA ploidy in human colon cancer 53
Il trattamento medico del carcinoma mammario. 53
Weekly administration of gemcitabine plus docetaxel in patients with advanced breast cancer: a phase 1 study. 52
Multiparametric assessment of the cell cycle effects of tamoxifen on MCF-7 human breast cancer cells. 52
Cell kinetics in human malignancies studied with in vivo administration of bromodeoxyuridine and flow cytometry 52
Monoclonal antibody Ki-67 as marker of proliferative activity in monoclonal gammopathies. 52
Relevance of age on survival of 341 patients with multiple myeloma treated with conventional chemotherapy: updated results of the MM87 prospective randomised protocol. 52
Cell kinetics in leukaemia and solid tumours studied with in vivo bromodeoxyuridine and flow cytometry 52
Totale 6.272
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.283
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.283
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020404 0 0 0 0 0 0 9 152 3 164 63 13
2020/20211.346 151 116 49 145 2 204 7 169 56 199 193 55
2021/2022810 5 2 21 11 20 32 19 31 41 16 127 485
2022/20232.425 301 127 25 238 317 257 0 134 914 14 53 45
2023/2024718 130 146 25 62 68 167 11 28 8 29 27 17
2024/2025476 42 208 54 73 41 53 5 0 0 0 0 0
Totale 9.535